These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6133715)

  • 1. The pharmacokinetics, plasma protein binding and time response relationships of 2-amino-5-phenyl-2-oxazolin-4-one (pemoline) in the horse.
    Igwe OJ; Blake JW
    Drug Metab Dispos; 1983; 11(2):120-5. PubMed ID: 6133715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat.
    Miller RP; Rotenberg KS; Adir J
    Drug Metab Dispos; 1977; 5(5):436-43. PubMed ID: 20291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
    Bortolotti A; Jiritano L; Bonati M
    Drug Metab Dispos; 1985; 13(2):227-31. PubMed ID: 2859173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of cephalothin in horse mares.
    Ruoff WW; Sams RA
    Am J Vet Res; 1985 Oct; 46(10):2085-90. PubMed ID: 4062011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Feb; 67(2):310-6. PubMed ID: 16454638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
    Soma LR; Uboh CE; Rudy JA; Perkowski SZ
    Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
    Chay S; Woods WE; Rowse K; Nugent TE; Blake JW; Tobin T
    Drug Metab Dispos; 1983; 11(3):226-31. PubMed ID: 6135581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
    Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
    Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative determination of pemoline in serum and urine after ingestion of therapeutic doses (author's transl)].
    Goenechea S; Wagner GM
    Arzneimittelforschung; 1977; 27(8):1604-5. PubMed ID: 578754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat.
    Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.